Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely cefotetan (as cefotetan disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefotetan disodium |
Inferred relationship |
Some |
|
Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefotetan disodium |
Inferred relationship |
Some |
|
cefotetandinatrium 20 mg/ml infusionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefotetan disodium |
Inferred relationship |
Some |
|
cefotetandinatrium 40 mg/ml infusionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefotetan disodium |
Inferred relationship |
Some |
|
cefotetandinatrium 10 g pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefotetan disodium |
Inferred relationship |
Some |
|
Product containing precisely cefotetan (as cefotetan disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefotetan disodium |
Inferred relationship |
Some |
1 |
Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefotetan disodium |
Inferred relationship |
Some |
1 |
Product containing precisely cefotetan (as cefotetan disodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefotetan disodium |
Inferred relationship |
Some |
1 |